Kaletra (ABT-378/r) approved.
Details and information sources on Kaletra (lopinavir plus low-dose ritonavir), a protease inhibitor approved last week.
James
J S
JS
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000191:economics / Q000600:supply & distribution; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000191:economics / Q000600:supply & distribution; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir